奥氮平与利培酮对老年精神分裂症患者血糖血脂的影响

被引:20
作者
黄兴兵 [1 ]
钟智勇 [2 ]
张晋碚 [2 ]
黄雄 [1 ]
魏钦令 [2 ]
王相兰 [2 ]
沐楠 [1 ]
温全球 [1 ]
机构
[1] 广州市脑科医院精神科
[2] 中山大学附属第三医院精神科
关键词
奥氮平; 利培酮; 体重; 血糖; 血脂;
D O I
暂无
中图分类号
R749.3 [精神分裂症];
学科分类号
摘要
目的探讨奥氮平与利培酮对老年精神分裂症患者血糖、血脂的影响。方法将44例老年精神分裂症患者随机分为两组,每组各22例,分别给予利培酮和奥氮平治疗,观察8 w。治疗前及治疗第8 w末检测体重指数、空腹血糖、胆固醇、甘油三酯。采用简明精神病量表评定临床疗效,并进行对比分析。结果利培酮组治疗前后体重指数、空腹血糖、胆固醇、甘油三酯差异均无显著性(P>0.05),奥氮平组治疗后上述各项水平明显升高,与治疗前比较均有显著性差异(P<0.05);两组简明精神病量表减分率与治疗前后的体重指数、空腹血糖、胆固醇、甘油三酯均无明显相关性(P>0.05)。结论奥氮平对老年精神分裂症患者的血糖、血脂影响较利培酮显著,两组疗效与患者的体重指数、血糖、血脂变化无必然联系。
引用
收藏
页码:1 / 3
页数:3
相关论文
共 9 条
[1]  
The appar-ent effects of ziprasidone on plasma lipids and glucose. Kingsbury SJ,Fayek M,Trufasiu D,et al. Journal of Clinical Psychiatry . 2001
[2]  
Severe hyper-glycemia associated with high doses of clozapine. Kammran A,Doraiswamy PM,JL,et al. American Journal of Psychiatry . 1994
[3]  
Antipsychotic drugs can af-fect hormone balance,weight gain,blood lipid disturbancesand diabetes are important. Melksson K,Hulting AL. Lakartidninger . 2001
[4]  
No association ofantipsychotic agent-induced weight gain with a DA receptorgene polymorphism and therapeutic response. Zhang ZJ,Yao ZJ,Zhang XB,et al. Acta Pharmacological Sinica . 2003
[5]  
Novelantipsychitics and new onset diabetes. Wrishing DA,Spellberg BJ,Erhart SM,et al. Biological Psychiatry . 1998
[6]  
Weightchange after an atypical antipsychotic switch. Ried LD,Renner BT,Bengtson MA,et al. Annals of Pharmacotherapy . 2003
[7]  
Antipsychotic-induced weight gain:a comprehensive research synthesis. Allison DB,Mentore JL,Heo M,et al. American Journal of Psychiatry . 1999
[8]  
Changes in glu-cose and cholesterol levels in patients with schizophreniatreated with typical and atypical antipsychotics. Lindenmayer JP,Czobor P,Vclavka J. American Journal of Psychiatry . 2003
[9]  
Antipsychotics-induced weight gain and therapeutic response:a differentialassociation. Czobor P,Volavkaj,Sheitmanb,et al. Journal of Clinical Psychopharmacology . 2002